Startups

Scientist/Senior Scientist, Immunology

NewLimit · South San Francisco · On-site

← All jobs
About NewLimit

NewLimit is extending human healthspan by unlocking regenerative potential. Backed by Kleiner Perkins.

About the role

NewLimit is seeking a highly motivated Scientist/Senior Scientist in Immunology to lead and execute key discovery-to-preclinical research efforts in inflammatory and autoimmune diseases, with a strong emphasis on T cell and regulatory T cell (Treg) biology. This role will design and implement in vitro screening assays to support lead selection and contribute to preclinical efficacy, safety, and mechanism-of-action studies.

What they're looking for

  • Ph.D. in immunology, cell biology, or a related field or BS/MS with 6+ years of relevant industry experience
  • Hands-on experience with multi-parameter flow cytometry
  • Experience designing in vivo models of autoimmune or inflammatory disease
  • Experience with primary immune cell isolation, ex vivo culture, and Treg functional assay
More about this role

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

NewLimit is seeking a highly motivated Scientist/Senior Scientist in Immunology to lead and execute key discovery-to-preclinical research efforts in inflammatory and autoimmune diseases, with a strong emphasis on T cell and regulatory T cell (Treg) biology. This role will design and implement in vitro screening assays to support lead selection and contribute to preclinical efficacy, safety, and mechanism-of-action studies. You will work closely with cross-functional partners to support program advancement toward IND-enabling studies.

  • Collaborate with Single Cell Technology, Epigenetic Editing, and Predictive Modeling teams to design, build, and evaluate epigenetic reprogramming interventions for aged T cells, including integration and...

Read the full posting on NewLimit's site ↗

Immunology

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.